Intravenous immunoglobulin for neuromuscular disease: Costs, benefits and reimbursement

Nature Clinical Practice Neurology

Volumn 5, Issue 3, 2009, Pages 119-

  Griffin, John W ^a   Hughes, Richard A C ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PREDNISOLONE;

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EDITORIAL; GUILLAIN BARRE SYNDROME; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; MOTOR NEUROPATHY; MYASTHENIA GRAVIS; NEUROMUSCULAR DISEASE; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; NEUROMUSCULAR DISEASES;

EID: 62549095546     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro1046     Document Type: Editorial

References (0)